FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to drugs and concerns a composition for intestinal dysbacteriosis correction, characterised by the fact that it is prepared on the basis of a consortium of lactobacilli strains providing a ratio of total short-chain monocarboxylic fatty acids of fractions (C2-C4) and a butyric acid isomer as 20:1 to 40:1.
EFFECT: composition under the invention provides personification of intestinal dysbacteriosis correction in the patients with a higher value of an invert correlation of total short-chain monocarboxylic fatty acids (C4-C6) to total fractions of their isomers (C4-C6) in faeces.
3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIBACTERIAL AGENT | 2011 |
|
RU2452506C1 |
COMPOSITION CONTAINING BACTERIAL WASTE PRODUCTS USEFUL FOR HUMAN BODY | 2013 |
|
RU2535152C1 |
ANTHELMINTHIC AGENT | 2010 |
|
RU2443427C1 |
DIURETIC AGENT | 2010 |
|
RU2442598C1 |
IMMUNOBIOLOGICAL ANTIALLERGIC AGENT (VERSIONS) AND LACTOBACILLUS ACIDOPHILUS STRAIN USED FOR PRODUCTION OF IMMUNOBIOLOGICAL ANTIALLERGIC AGENT | 2009 |
|
RU2460781C2 |
"ASTRAKHANSKY KUMISS" AERATED CULTURED MILK PRODUCT (VERSIONS) | 2010 |
|
RU2452187C2 |
IMMUNOBIOLOGICAL ANTIALLERGIC AGENT (VERSIONS) AND Lactobacillus acidophilus 100 "аш" PA STRAIN USED FOR PRODUCTION OF IMMUNOBIOLOGICAL ANTIALLERGIC AGENT | 2008 |
|
RU2431663C2 |
IMMUNOBIOLOGIAL ANTIALLERGIC AGENT (VERSIONS), LACTOBACILLUS ACIDOPHILUS NKJC STRAIN, LACTOBACILLUS ACIDOPHILUS JCH STRAIN, LACTOBACILLUS ACIDOPHILUS KAA STRAIN | 2009 |
|
RU2393214C1 |
"ASTRAKHANSKY SHUBAT" AERATED CULTURED MILK PRODUCT (VERSIONS) | 2010 |
|
RU2437542C1 |
ORAL COMPOSITION CONTAINING NONPATHOGENIC MICROORGANISMS SHOWING ABILITY TO NORMALISE INTESTINAL MICROFLORA (VERSIONS) | 2008 |
|
RU2453320C2 |
Authors
Dates
2011-10-20—Published
2010-01-29—Filed